{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:44:50Z","timestamp":1791773090049,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jhep.2015.12.003","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T21:35:47Z","timestamp":1450301747000},"page":"834-842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats"],"prefix":"10.1016","volume":"64","author":[{"given":"Federica","family":"Cerini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vilaseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Lafoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oihane","family":"Garc\u00eda-Irigoyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Garc\u00eda-Calder\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh M.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Reverter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Gracia-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Garc\u00eda-Pag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.12.003_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.12.003_b0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2012.03.007","article-title":"Functional aspects on the pathophysiology of portal hypertension in cirrhosis","volume":"57","author":"Garcia-Pagan","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.12.003_b0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2007-1007128","article-title":"Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis","volume":"19","author":"Pinzani","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2015.12.003_b0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-008-8091-0","article-title":"Inflammatory pathways in liver homeostasis and liver injury","volume":"36","author":"Tacke","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jhep.2015.12.003_b0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1042\/bj3330121","article-title":"Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1","volume":"333","author":"Chambers","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2015.12.003_b0030","doi-asserted-by":"crossref","first-page":"35584","DOI":"10.1074\/jbc.M003188200","article-title":"Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1","volume":"275","author":"Chambers","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.12.003_b0035","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2003.032136","article-title":"A role for thrombin in liver fibrosis","volume":"53","author":"Duplantier","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.12.003_b0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cld.2008.09.013","article-title":"Parenchymal extinction: coagulation and hepatic fibrogenesis","volume":"13","author":"Anstee","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2015.12.003_b0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1582-4934.2009.00980.x","article-title":"The coagulation factor Xa\/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm","volume":"14","author":"Borensztajn","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jhep.2015.12.003_b0050","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/hep.510270221","article-title":"Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury","volume":"27","author":"Marra","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.12.003_b0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","article-title":"PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation","volume":"39","author":"Fiorucci","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.12.003_b0060","doi-asserted-by":"crossref","first-page":"G226","DOI":"10.1152\/ajpgi.00444.2007","article-title":"Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis","volume":"294","author":"Rullier","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.12.003_b0065","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0168-8278(01)00285-9","article-title":"Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors","volume":"36","author":"Gaca","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.12.003_b0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2353\/ajpath.2008.070347","article-title":"Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation","volume":"172","author":"Borensztajn","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2015.12.003_b0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.24784","article-title":"Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells","volume":"55","author":"Knight","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.12.003_b0080","first-page":"1232","article-title":"Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis)","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.12.003_b0085","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.12.003_b0090","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1160\/TH09-02-0134","article-title":"Direct inhibitors of coagulation proteins \u2013 The end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?","volume":"102","author":"Laux","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2015.12.003_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.phrs.2004.04.009","article-title":"A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat","volume":"51","author":"Abdel-Salam","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jhep.2015.12.003_b0100","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10620-006-9595-1","article-title":"The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis","volume":"52","author":"Assy","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2015.12.003_b0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2006.08.023","article-title":"Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat","volume":"46","author":"Abe","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.12.003_b0110","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.12.003_b0115","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.fjc.0000159878.66325.fc","article-title":"Comparison of the vasodilatory effect of nadroparin, enoxaparin, dalteparin, and unfractioned heparin in human internal mammary artery","volume":"45","author":"Tasatargil","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jhep.2015.12.003_b0120","first-page":"234","article-title":"Modulation of the effect of vascular endothelial growth factor on endothelial cells by heparin: critical role of nitric oxide-mediated mechanisms","volume":"18","author":"Yague","year":"2005","journal-title":"J Nephrol"},{"key":"10.1016\/j.jhep.2015.12.003_b0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/HYPERTENSIONAHA.110.156877","article-title":"Heparin induces rat aorta relaxation via integrin-dependent activation of muscarinic M3 receptors","volume":"56","author":"Paredes-Gamero","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jhep.2015.12.003_b0130","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2012.12.012","article-title":"Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats","volume":"58","author":"Di Pascoli","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.12.003_b0135","first-page":"203","article-title":"Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A\/J mice","volume":"141","author":"Frizelle","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2015.12.003_b0140","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2007.01.020","article-title":"Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl(4) cirrhotic rats","volume":"15","author":"Abraldes","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.12.003_b0145","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/hep.22166","article-title":"Increased oxidative stress in cirrhotic rat livers: a potential mechanism contributing to reduced nitric oxide bioavailability","volume":"47","author":"Gracia-Sancho","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.12.003_b0150","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/gut.2010.220913","article-title":"Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver","volume":"60","author":"Gracia-Sancho","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.12.003_b0155","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1111\/liv.12337","article-title":"Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair","volume":"34","author":"Garcia-Irigoyen","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.12.003_b0160","doi-asserted-by":"crossref","first-page":"G840","DOI":"10.1152\/ajpgi.90639.2008","article-title":"Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice","volume":"296","author":"Luyendyk","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.12.003_b0165","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/labinvest.3700171","article-title":"A novel model of occlusive thrombus formation in mice","volume":"84","author":"Sasaki","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2015.12.003_b0170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jhep.2012.09.010","article-title":"Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats","volume":"58","author":"Guillaume","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.12.003_b0175","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","article-title":"KLF2 exerts anti-fibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins","volume":"64","author":"Marrone","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.12.003_b0180","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.12.003_b0185","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","article-title":"Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.12.003_b0190","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.12.003_b0195","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000103655","article-title":"Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment","volume":"24","author":"Lisman","year":"2007","journal-title":"Dig Surg"},{"key":"10.1016\/j.jhep.2015.12.003_b0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-8278(02)00324-0","article-title":"Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats \u2013 A possible mechanism of intrasinusoidal microthrombus formation and liver dysfunction","volume":"38","author":"Kume","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.12.003_b0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1465-9921-10-30","article-title":"Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury","volume":"10","author":"de Visser","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.jhep.2015.12.003_b0210","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ajpath.2012.02.011","article-title":"Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury","volume":"180","author":"Sullivan","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2015.12.003_b0215","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.27387","article-title":"Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces","volume":"61","author":"Simonetto","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.12.003_b0220","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2015.12.003_b0225","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815008041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815008041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T10:46:05Z","timestamp":1653821165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815008041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0168827815008041"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.12.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726028173.793547486","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726028173.793520139","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726028173.793533346","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}